ArticleEuropean journal of pediatrics2024

Drug levels of VEDOLIZUMAB in patients with pediatric-onset inflammatory bowel disease in a real-life setting.

Maria Hemming-Harlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.